Investigating the benefits of endovascular thrombectomy for stroke patients.
StrokeNet Thrombectomy Endovascular Platform (STEP)
This study is looking to find better treatment options for people who have had a stroke caused by a blocked blood vessel, by testing a procedure called endovascular thrombectomy (EVT) on a broader group of patients to see how well it works.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Medical University of South Carolina NIH-funded |
| Lab location | 1 site (Charleston, United States) |
| Project ID | NIH-10547985 on NIH RePORTER |
What this research studies
This research focuses on improving treatment options for patients suffering from acute ischemic stroke, particularly those with large vessel occlusion. It aims to assess the effectiveness of endovascular thrombectomy (EVT) in a wider range of patients than previously studied. The research will utilize a multi-factorial, adaptive trial design to explore various aspects of EVT, including its indications, devices, and accompanying medical therapies. By developing a robust clinical trial platform, the study seeks to provide clearer answers regarding the management of stroke patients who may benefit from EVT.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients experiencing acute ischemic stroke with large vessel occlusion who may be eligible for endovascular thrombectomy.
Not a fit: Patients with strokes not caused by large vessel occlusion or those who are not candidates for endovascular thrombectomy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment protocols for stroke patients, potentially reducing disability and enhancing recovery outcomes.
How similar studies have performed: Previous studies have shown that endovascular thrombectomy can be highly beneficial for selected stroke patients, indicating a promising avenue for further exploration.
Where this research is happening
Charleston, United States
- Medical University of South Carolina — Charleston, United States (Active)
Researchers
- Principal investigator: Elm, Jordan J. — Medical University of South Carolina
- Study coordinator: Elm, Jordan J.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.